These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 22847158

  • 1. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
    He H, Wu G, Li W, Cao Y, Liu Y.
    Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
    [Abstract] [Full Text] [Related]

  • 2. Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues.
    Huang P, Qiu J, You J, Hong J, Li B, Zhou K, Chen G, Yuan Y, Zou R.
    Biomarkers; 2012 Aug; 17(5):422-9. PubMed ID: 22537152
    [Abstract] [Full Text] [Related]

  • 3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.
    World J Gastroenterol; 2015 Jun 07; 21(21):6649-59. PubMed ID: 26074703
    [Abstract] [Full Text] [Related]

  • 4. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
    Khanna A, Böckelman C, Hemmes A, Junttila MR, Wiksten JP, Lundin M, Junnila S, Murphy DJ, Evan GI, Haglund C, Westermarck J, Ristimäki A.
    J Natl Cancer Inst; 2009 Jun 03; 101(11):793-805. PubMed ID: 19470954
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
    Yang X, Qu K, Tao J, Yin G, Han S, Liu Q, Sun H.
    Biochem Biophys Res Commun; 2018 Jan 08; 495(2):1807-1814. PubMed ID: 29175329
    [Abstract] [Full Text] [Related]

  • 7. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
    Xue Y, Wu G, Wang X, Zou X, Zhang G, Xiao R, Yuan Y, Long D, Yang J, Wu Y, Xu H, Liu F, Liu M.
    Med Oncol; 2013 Mar 08; 30(1):406. PubMed ID: 23275123
    [Abstract] [Full Text] [Related]

  • 8. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S.
    Oncotarget; 2015 Dec 01; 6(38):41383-97. PubMed ID: 26515591
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D, Chen Y, Yan Y, Pan J, Xing W, Li Q, Zeng W.
    BMC Cancer; 2017 Aug 18; 17(1):553. PubMed ID: 28821282
    [Abstract] [Full Text] [Related]

  • 10. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK, Sun Q, Fan YC, Gao S, Zhao J, Li F, Jia YB, Liu C, Wang LY, Li XY, Ji XF, Wang K.
    J Gastroenterol Hepatol; 2016 Feb 18; 31(2):484-92. PubMed ID: 26313014
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
    Liu N, He QM, Chen JW, Li YQ, Xu YF, Ren XY, Sun Y, Mai HQ, Shao JY, Jia WH, Kang TB, Zeng MS, Ma J.
    Mol Cancer; 2014 May 19; 13():111. PubMed ID: 24884612
    [Abstract] [Full Text] [Related]

  • 12. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
    Ji F, Zhang ZH, Zhang Y, Shen SL, Cao QH, Zhang LJ, Li SQ, Peng BG, Liang LJ, Hua YP.
    BMC Cancer; 2018 Apr 24; 18(1):460. PubMed ID: 29690860
    [Abstract] [Full Text] [Related]

  • 13. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H, Jiang S, Zhang Y, Pan K, Xia J, Chen M.
    World J Surg Oncol; 2014 Jul 18; 12():226. PubMed ID: 25037578
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
    Li M, Luo RZ, Chen JW, Cao Y, Lu JB, He JH, Wu QL, Cai MY.
    J Transl Med; 2011 Jan 05; 9():5. PubMed ID: 21205329
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
    Yang SZ, Wang JT, Yu WW, Liu Q, Wu YF, Chen SG.
    World J Gastroenterol; 2015 Jul 21; 21(27):8418-24. PubMed ID: 26217094
    [Abstract] [Full Text] [Related]

  • 17. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.
    Ren J, Li W, Yan L, Jiao W, Tian S, Li D, Tang Y, Gu G, Liu H, Xu Z.
    Br J Cancer; 2011 Dec 06; 105(12):1905-11. PubMed ID: 22075943
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Cheng Y, Chen X, Ye L, Zhang Y, Liang J, Liu W, Zhou B, Zheng S, Huang Y, Chen G, Deng Y, Zhang Q, Yang Y.
    Cell Physiol Biochem; 2018 Dec 06; 51(6):2746-2759. PubMed ID: 30562736
    [Abstract] [Full Text] [Related]

  • 20. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
    Wu S, Chen X, Hu C, Wang J, Shen Y, Zhong Z.
    Med Sci Monit; 2017 Dec 01; 23():5705-5713. PubMed ID: 29192136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.